Endotoxemia and its association with immune and coagulopathy responses in severe community-acquired pneumonia and COVID-19. [PDF]
Blot M +12 more
europepmc +1 more source
Targeting Vascular Inflammation In Patients with Community-Acquired Pneumonia (TIN-CAP): protocol for a multicentre, randomised, double-blind, placebo-controlled trial. [PDF]
Stotts C +21 more
europepmc +1 more source
Necrotizing pneumonia due to blastomycosis: Diagnostic challenges and the emerging role of cell-free DNA testing. [PDF]
Tubberville E +3 more
europepmc +1 more source
Combining Geriatric Nutritional Risk Index with Total Cholesterol to Predict Pneumonia Mortality Risks in a Cohort of General Older Adults. [PDF]
Yu R +9 more
europepmc +1 more source
Lipidomics changes in bronchoalveolar lavage fluid of refractory mycoplasma pneumoniae pneumonia: LC-MS-based analysis of potential biomarkers and pathogenesis. [PDF]
Ma M, Shi J, Wang W, Huang H, Li X.
europepmc +1 more source
Research advances in pathogenic mechanisms and host response of mycoplasma pneumoniae pneumonia in children: a metabolomics perspective. [PDF]
Dai Y +5 more
europepmc +1 more source
The Paradox of Metachronous Lipoid Pneumonia. [PDF]
Kobayashi H.
europepmc +1 more source
Doxycycline for Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Pneumonia in Children: Clinical Updates and Therapeutic Insights Post-COVID-19. [PDF]
Chen R, Xu Z.
europepmc +1 more source
Bis-1,2,4-triazole derivatives as potential antioxidants for pneumonia therapy. [PDF]
Korol N +4 more
europepmc +1 more source
Potential role of serological biomarkers in the diagnosis and prediction of community-acquired pneumonia in elderly individuals. [PDF]
Hou C, Jin YF, Li J.
europepmc +1 more source

